簡易檢索 / 詳目顯示

研究生: 黃傢裕
Huang, Chia-Yu
論文名稱: 壹、beta-硝基苯乙烯的應用—4-芳基四氫異喹啉、3-芳基吲哚、2-芐基苯並呋喃及2-芳基色滿衍生物的合成 貳、茚並異喹啉的合成
I. Application of beta-Nitrostyrene — Synthesis of 4-ArylTHIQ, 3-Arylindole, 2-Benzylbenzofuran, and 2-Arylnitrochroman Derivatives II. Synthesis of Indenoisoquinolines
指導教授: 姚清發
Yao, Ching-Fa
學位類別: 博士
Doctor
系所名稱: 化學系
Department of Chemistry
論文出版年: 2017
畢業學年度: 105
語文別: 中文
論文頁數: 313
中文關鍵詞: 4-芳基四氫異喹啉3-芳基吲哚2-苄基苯並呋喃2-芳基色滿茚並異喹啉
英文關鍵詞: 3-aryltetrahydroisoquinoline, 3-arylindole, 2-benzylbenzofuran, 2-arylchroman, indenoisoquinoline
DOI URL: https://doi.org/10.6345/NTNU202202679
論文種類: 學術論文
相關次數: 點閱:46下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 本論文分為兩個章節,每章節各自獨立,包含前言、研究目標、實驗結果
    與討論,以及結論。
    第壹章節探討beta-硝基苯乙烯衍生物在化學合成上的發展性與應用性,可以分為四個部分,分別為4-芳基四氫異喹啉、3-芳基吲哚、2-芐基苯並呋喃及2-芳基色滿四種化合物的合成。第一部分,beta-硝基苯乙烯與芳環用三氯化鋁催化傅-克烷化反應合成硝基烷,其還原後的胺類以傅-克反應或皮克特-施彭格勒反應得到4-芳基四氫異喹啉衍生物;若將胺類以銅試劑催化烏爾曼反應則是新穎的3-芳基吲哚合成法,為第二部分。第三部分,將beta-硝基苯乙烯衍生物還原為硝基烷,經過內夫反應合環得到2-苄基苯並呋喃;第四部份則將硝基烯衍生物作為中間產物,在鹼催化下一鍋化合成2-芳基色滿。
    第貳章節為茚並異喹啉的合成,分成三個部分,第一部分以2-碘苯甲醯胺與茚滿二酮為起始物,在乙腈中銅催環化反應得到茚並異喹啉衍生物。第二部分為第一部分的反應條件的改良,除了將溶劑改為水,也縮短了反應時間跟減少銅試劑的使用量。第三部分為茚並異喹啉的合成展望,嘗試由2-鹵苯甲酸與茚滿二酮作為起始物,在反應過程中加入胺類以一鍋化合成茚並異喹啉衍生物,可減少合成步驟並提升原子效益。

    The content of the thesis is divided into two chapters, each chapter individually including preface, research goal, results and discussions, and conclusion.
    Chapter I discuss about the applicability of beta-nitrostyrene derivatives for the synthesis of four types of structurally different compounds such as 4-aryltetrahydroisoquinoline, 3-arylindole, 2-benzylbenzofuran and 2-arylchroman derivatives. This chapter is divided into four parts. In the first part, the amines derived from nitroalkanes, which was synthesized via AlCl3-catalyzed Friedel-Crafts alkylation and reductive amination of beta-nitrostyrenes and arenes, underwent Friedel-Crafts cyclization or Pictet-Spengler reaction to produce 4-aryltetrahydroisoquinolines. In the second part, the amines were treated with copper catalyst to furnish 3-arylindoles. For third and fourth parts, nitroalkene derivatives modified from beta-nitrostyrenes were subjected to Nef reaction to yield 2-benzylbenzofurans, or treated with base to do Michael addition to obtain 2-arylchroman derivatives.
    Chapter II is the synthesis of indenoisoquinolines, and is divided into three parts. The first part using 2-iodobenzamides and 1,3-indandiones as starting materials, which were transformed into indenoisoquinoline derivatives by copper-catalyzed cyclization in acetonitrile . The second part deals with the water-mediated synthesis of the same compounds under reduced amount of copper catalyst. The third part is a progressive project. We replaced 2-iodobenzamides with 2-halobenzoic acids as starting materials, after coupling with 1,3-indandione the amine derivative could be inserted and cyclized to afford the desired indenoisoquinolines. This one-pot water-mediated synthesis can save synthetic steps and improve atom efficiency.

    中文摘要 I 英文摘要 II 第壹章、beta-硝基苯乙烯的應用—4-芳基四氫異喹啉、 3-芳基吲哚、2-苄基苯並呋喃及2-芳基色滿衍生物的合成 1-1、前言 1 1-1-1、4-芳基四氫異喹啉(4-arylTHIQ)衍生物的介紹 1 1-1-2、3-芳基吲哚(3-arylindole)衍生物的介紹 6 1-1-3、2-苄基苯並呋喃(2-benzylbenzofuran)衍生物的介紹 8 1-1-4、2-芳基色滿(2-arylchroman)衍生物的介紹 11 1-2、研究目標 12 1-3、實驗結果與討論 14 1-3-1、4-芳基四氫異喹啉衍生物的合成 14 1-3-2、3-芳基吲哚衍生物的合成 17 1-3-3、2-苄基苯並呋喃衍生物的合成 23 1-3-4、2-芳基色滿衍生物的合成 30 1-4、結論 39 1-5、實驗方法 41 1-5-1、分析儀器及基本實驗操作 41 1-5-2、實驗步驟 42 1-6、參考文獻 46 1-7、光譜資料 51 1-8、光譜附圖 77 第貳章、茚並異喹啉衍生物的合成 2-1、前言 240 2-1-1、茚並異喹啉(Indenoisoquinoline)衍生物的介紹 240 2-2、研究目標 243 2-3、實驗結果與討論 244 2-3-1、茚並異喹啉的合成 244 2-3-1、水相反應合成茚並異喹啉 248 2-3-3、後續展望—由苯甲酸一鍋化水相合成茚並異喹啉 253 2-4、結論 255 2-5、實驗方法 257 2-5-1、分析儀器及基本實驗操作 257 2-5-2、實驗步驟 258 2-6、參考文獻 258 2-7、光譜資料 262 2-8、光譜附圖 272

    Part 1.
    1. (a) M. J. Zanwar, V. Kavala, S. D. Gawande, C.-W. Kuo, T.-S. Kuo, M.-L. Chen, C.-H. He, C.-F. Yao, Eur. J. Org. Chem. 2013, 36, 8288-8298. (b) Z. Tu, B. R. Raju, T.-R. Liou, V. Kavala, C.-W. Kuo, Y. Jang, Y.-H. Shih, C.-C. Wang, C.-F. Yao, Tetrahedron 2009, 65, 2436-2442. (c) K.-H. Shen, J.-T. Liu, Y.-R. Wu, C.-F. Yao, Synth. Commun. 2007, 37, 3677-3687. (d) C. Lin, J. Hsu, M. N. V. Sastry, H. Fang, Z. Tu, J.-T. Liu, C.-F. Yao, Tetrahedron 2005, 61, 11751-11757. (e) M.-C. Yan, Y.-J. Jang, W.-Y. Kuo, Z. Tu, K.-H. Shen, T.-S. Cu, C.-H. Ueng, C.-F. Yao, Heterocycles 2002, 57, 1033-1048. (f) J.-T. Liu, Y.-J. Jang, Y.-K. Shih, S.-R. Hu, C.-M. Chu, C.-F. Yao, J. Org. Chem. 2001, 66, 6021-6028.
    2. (a) Bondinell, W. E.; Chapin, F. W.; Girard, G. R.; Kaiser, C.; Krog, A. J.; Pavloff, A. M.; Schwartz, M. S.; Silvestri, J. S.; Vaidya, P. D.; Lam, B. L.; Wellman, G. R.; Pendleton, R. G. J. Med. Chem. 1980, 23, 506-511. (b) Stambach, J. F.; Kanmacher, I.; Jung, L.; Schott, C.; Heitz, C.; Stoclet, J. C. Eur. J. Med. Chem. 1993, 28, 427-432. (c) McNaugh, K. St. P.; Thull, U.; Carrupt, P.-A.; Altomare, C.; Cellamare, S.; Carotti, A.; Testa, B.; Jenner, P.; Marsden, C. D. Biochem. Pharmacol. 1996, 51, 1503-1511. (d) Clark et al. Patent: US20070015737 A1 2007. (e) Nakamura, S.; Nakashima, S.; Tanabe, G.; Oda, Y.; Yokota, N.; Fujimoto, K.; Matsumoto, T.; Sakuma, R.; Ohta, T.; Ogawa, K.; Nishida, S.; Miki, H.; Matsuda. H.; Muraoka, O.; Yoshikawa, M. Bioorg. Med. Chem.2013, 21, 779-787.
    3. Xintria Pharmaceutical Cooperation, Inc. Patent: WO2010104595 A1 2010.
    4. (a) Young, Y. C.; Kwon, O. S.; Han, E. S.; Song, J. H.; Shin, Y. K.; Lee, C. S. Biochem. Pharmacol.2002, 63, 495-505. (b) Yang, J.-H.; Li, L.; Wang, Y.-S.; Zhao, J.-F.; Zhang, H.-B.; Luo, S.-D. Helv. Chim. Acta 2005, 88, 2523-2526. (c) O’Brien, P.; Carrasco-Pozo, C.; Speisky, H. Chem. Biol. Interact. 2006, 159, 1-17. (d) Zhang, A.; Zhang, Y.; Branfman, A. R.; Baldessarini, R. J.; Neumeyer, J. L. J. Med. Chem. 2007, 50, 171-181. (e) Han, Z.; Zheng, Y.; Chen, N.; Luan, L.; Zhou, C.; Gan, L.; Wu, Y. J. Chromatogr. A 2008, 1212, 76-81.
    5. (a) Sutin, E. L.; Jacobowitz, D. M. Prog. Brain Res.1991, 88, 3-14. (b) Hong et al. Patent: WO03103670 A1 2003.
    6. (a) Frydman, B.; Bendisch, R.; Deulofeu, V. Tetrahedron 1958, 4, 342-350. (b) Kutchan et al. Patent: US20080196123 A1 2008. (c) Yusupov, M. M.; Karimov, A.; Levkovich, M. G.; Abdullaev, N. D.; Shakirov, R. Chem. Nat. Compd. 1993 , 29, 43-48. (d) Karimov, A.; Levkovich, M. G.; Abdullaev, N. D.; Shakirov, R. Chem. Nat. Compd. 1993, 29, 331-334. (e) Baures, P. W.; Peterson, S. A.; Kelly, J. W. Bioorg. Med. 1998, 6, 1389-1401.
    7. Hoffmann-La Roche Inc. Patent: US3947456 A 1976.
    8. (a) Cherpillod, C.; Omer, L. M. J. Int. Med. Res. 1981, 9(5), 324-329. (b) Culig, J.; Ehsanullah, R. S.; Hallett, C.; Iliopoulou, A.; Matheson, I., Turner, P. Br. J. Clin. Pharmacol. 1983, 15(5), 537-543. (c) Omer, O. L.; Díaz-Olivera, M.; Ismail, S. Methods Find Exp. Clin. Pharmacol. 1984, 6(3), 147-151. (d) Gasić, S.; Korn, A.; Eichler, H. G. Clin. Pharmacol. Ther. 1986, 39(5), 582-585. (e) Funke, H. J.; Holtmann, W.; Ismail, S.; Jansen, W.; Leonhardt, K. F.; Muth, H.; Omer, L. M.; O'Connolly, M.; Ramm, H. Pharmacopsychiatry. 1986, 19(3), 120-123. (f) Lamb, R. J.; Griffiths, R. R. Psychopharmacology (Berl). 1990, 102(2), 183-190. (g) Nikachi, N.; Kuichi, Y.; Inagaki, M.; Inazu, M.; Yamazaki, Y.; Oguchi, K. Eur J Pharmacol. 1995, 281(2), 195-203.
    9. Albany Molecular Research, Inc. Patent: WO2010132442 A1 2010.
    10. Albany Molecular Research, Inc. Patent: WO2010132437 A1 2010.
    11. Ghorai, J.; Anbarasan, P. J. Org. Chem. 2015, 80, 3455-3461.
    12. Tu, Z.; Raju, B. R.; Liou, T.-R.; Kavala, V.; Kuo, C.-W.; Jang, Y.; Shih, Y.-H.; Wang, C.-C.; Yao, C.-F. Tetrahedron Lett. 2009, 65, 2436-2442.
    13. Elgorashi, E. E.; Stafford, G. I.; Jäger, A. K.; van Staden, J. Planta Med. 2004, 70, 260-262. (b) Elgorashi, E. E.; Stafford, G. I.; Jäger, A. K.; van Staden, J. Planta Med. 2006, 72, 470-473.
    14. Brossi, A.; Teitel, S. Tetrahedron Lett. 1970, 6, 417-419.
    15. Couture, A.; Deniau, E.; Woisel, P.; Grandclaudon, P.; Carpentier, J. F. Tetrahedron Lett. 1996, 21, 3697-3700.
    16. Honda, T.; Namiki, H.; Satoh, F. Org. Lett. 2001, 3, 631-633.
    17. Ruchirawat, S.; Tontoolarug, S.; Sahakitpichan, P. Heterocycles 2001, 55, 635-640.
    18. Kumar, A. S.; Ghosh, S.; Soundararajan, R.; Mehta, G. N. Synth. Commun. 2010, 40, 1588-1594.
    19. (a) Lam, T. K.; Gallicchio, L.; Lindsley, K.; Shiels, M.; Hammond, E.; Tao, X.-G.; Chen, L.; Robinson, K. A.; Caulfield, L. E.; Herman, J. G.; Guallar, E.; lberg, A. J. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 189-195. (b) Navarro, S. L.; Li, F.; Lampe, J.W. Food Funct. 2011, 2, 579-587.
    20. Cole, S. W.; Hopkins, F. G. J. Physiol. 1903, 29, 451-466.
    21. (a) Chang, P.-C.; Lai, C.-Y.; Nakagawa-Goto, K.; Hung, H.-Y.; Chen, T.-H.; Wu, P.-C.; Zhu, H.; Sedykh, A.; Bastow, K. F.; Lee, K.-H. J. Med. Chem. 2010, 53, 6699-6705. (b) Guh, J.-H.; Chang, W.-H.; Chang, C.-S.; Chiang, P.-C.; Ho, Y.-F.; Liu, J.-F.; Chang, K.-W. Br. J. Pharmacol. 2010, 160, 1677-1689. (c) Wansi1, J. D.; Happil, E. N.; Bavoual, J. L. D.; Devkota, K. P.; Sewald, N. Planta Med. 2012, 78, 71-75. (d) Mirza, B.; Jafri, L.; Ansari, F. L.; Jamil, M.; Kalsoom, S.; Qureishi, S. Chem. Biol. Drug Des. 2012, 79, 950-959.
    22. (a) Voelter, W.; Al-Hiari1, Y. M.; Qaisi, A. M.; El-Abadelah, M. M. Monatsh. Chem. 2006, 137, 243-248. (b) Smith, B. A.; Neal, C. L.; Chetram, M.; Vo, B.; Mezencev, R.; Hinton, C.; Odero-Marah, V. A. J. Nat. Med. 2013, 67, 607-618.
    23. (a) Pittayakhajonwut, P.; Intaraudom, C.; Rachtawee, P.; Suvannakad, R. Tetrahedron 2011, 67, 7593-7597. (b) Ma, W.-H.; Qin, L.-P. Chem. Nat. Compd. 2014, 50, 776-777.
    24. (a) Pedras, M. S. C.; Hossain, M. Bioorg. Med. Chem. 2007, 15, 5981-5996. (b) de Koning, C. B.; Leboho, T. C.; Michael, J. P.; van Otterlo, W. A. L.; van Vuuren, S. F. Bioorg. Med. Chem. 2009, 19, 4948-4951. (c) Srivastava, R. S.; Murru, S.; Gallo, A. A. Eur. J. Org. Chem. 2011, 11, 2035-2038.
    25. Wu, T.-S.; Liou, M.-J.; Lee, C.-J.; Jong, T.-T.; McPhail, A. T.; McPhail, D. R.; Lee, K.-H. Tetrahedron Lett. 1989, 30, 6649-6652.
    26. (a) Ragaini, F.; Rapetti, A.; Visentin, E.; Monzani, M.; Caselli, A.; Cenini. S. J. Org. Chem. 2006, 71, 3748-3753. (b) Sheu, J.-H.; Chen, Y.-K.; Chung, H.-F.; Sung, P.- J.; Lin, S.-F. Heterocycles 1996, 43, 1751-1758.
    27. Zhu, J.; Jia, Y. J. Org. Chem. 2006, 71, 7826-7834.
    28. Zhang, Z.; Hu, Z.; Yu, Z.; Lei, P.; Chi, H.; Wang, Y.; He, R. Tetrahedron Lett. 2007, 48, 2415-2419.
    29. Mahadevan, K. M.; Siddalingamurthy, E.; Masagalli, J. N.; Harishkumar, H. N. Tetrahedron Lett. 2013, 54, 5591-5596.
    30. Chen, S.; Liao, Y.; Zhao, F.; Qi, H.; Liu, S. Deng, G.-J. Org. Lett. 2014, 16, 1618-1621.
    31. (a) Sardari, S.; Mori, Y.; Horita, K.; Micetich, R. G.; Nishibe, S.; Daneshtalab, M. Bioorg. Med. Chem. 1999, 7, 1933-1940. (b) Scharf et al. Patent: US20070154393 A1 2007.
    32. (a) Luca, L. D.; Nieddu, G.; Porcheddu, A.; Giacomelli, G. Curr. Med. Chem., 2009, 16, 1-20. (b) Banskota, A. H.; Tezuka, Y.; Midorikawa, K.; Matsushige, K.; Kadota, S. J. Nat. Prod. 2000, 63, 1277.
    33. Pei, T.; Chen, C.-y.; DiMichele, L.; Davies, I. W. Org. Lett. 2010, 12, 4972-4975.
    34. (a) Maurya, R.; Singh, R.; Deepak, M.; Handa, S. S.; Yadav, P.; Mishra, P. K. Phytochemistry 2004, 65, 915-920. (b) Maurya, R.; Rawat, P.; Kumar, M.; Rahuja, N., Srivastava, D. S. L.; Srivastava, A. K. Bioorg. Med. Chem. 2011, 21, 228-233.
    35. Malamas, M. S.; Sredy, J.; Moxham, C.; Katz, A.; Xu, W.; McDevitt, R.; Adebayo, F. O.; Sawicki, D. R.; Seestaller, L.; Sullivan, D.; Taylor, J. R. J. Med. Chem. 2000, 43, 1293-1310.
    36. Lau, C. K.; Bélanger, P. C.; Scheigetz, J.; Dufresne, C.; Williams, H. W. R.; Maycock, A. L.; Guindon, Y.; Bach, T.; Dallob, A. L.; Denis, D.; Ford-Hutchinson, A. W.; Gale, P. H.; Hopple, S. L.; Letts, L. G.; Luell, S.; McFarlane, C. S.; MacIntyre, E.; Meurer, R.; Miller, D. K.; Piechuta, H.; Riendeau, D.; Rokach, J.; Rouzer, C. J. Med. Chem. 1989, 32, 1190-1197.
    37. Boutin, J. A.; Séverine, D.; Legros, C.; Brasseur, C.; Cohen, W.; Guenin, S.-P.; Delagrange, P.; Malpaux, B.; Ouvry, C.; Cogé, F.; Nosjean, O. Eur. J. Pharmacol. 2012, 667, 15-21.
    38. Hartley, R. C.; Guthrie, E. J.; Macritchie, J. Tetrahedron Lett. 2000, 41, 4987-4990.
    39. Lei, Z.; Shi, Y.; Xiao, Q.; Liu, Y.; Ye, F.; Zhang, Y.; Wang, J. Org. Lett. 2011, 13, 968-971.
    40. Ghosh, S.; Das, J. Tetrahedron Lett. 2011, 52, 1112-1116.
    41. (a) Orvig, C.; Green, D. E.; Bowen, M. L.; Scott, L. E.; Storr, T.; Merkel, M.; Böhmerle, K., Thompson, K. H.; Patrick, B. O.; Schugar, H. J. Dalton Trans. 2010, 39, 1604-1615. (b) Liau, I.; Tai, W.-Y.; Yang, Y.-C.; Lin, H.-J.; Huang, C.-P.; Cheng, Y.-L.; Chen, M.-F.; Yen, H.-L. J. Phys. Chem. B 2010, 114, 15642-15649. (c) Sashidhara, K. V.; Palnati, G. R.; Dodda, R. P.; Sonkar, R.; Khanna, A. K.; Bhatia, G. Eur. J. Med. Chem. 2012, 57, 302-310.
    42. (a) Ray, S.; Tripathi, S.; Dwivedy, I.; Dhar, J. D.; Dwivedy, A. Bioorg. Med. Chem. 1997, 16, 2131-2136. (b) Dhar, A.; Srivastava, A. World J. Surg. 2007, 31, 1178-1184. (c) Gupta, A.; Dwivedy, I.; Grover, A.; Srivastava, V.; Singh, M. M.; Ray, S. Bioorg. Med. Chem. 2008, 18, 4102-4105. (d) Sahu, D. P.; Kumar, S.; Deshpande, S.; Chandra, V.; Kitchlu, S.; Dwivedi, A.; Nayak, V. L.; Konwar, R.; Prabhakar, Y. S. Bioorg. Med. Chem. 2009, 17, 6832-6840. (e) Jawahar, L. Contraception, 2010, 81, 275-280.
    43. (a) Strowig, S. M.; Raskin, P. Diabetes Care 2005, 28, 1562-1567. (b) Cohen, J. S. Diabetologia 2006, 49, 1454-1455.
    44. (a) Maurette, M.-T.; Oliveros, E.; Tournaire, C.; Croux, S.; Beck, I.; Hocquaux, M.; Braun, A. M. J. Photochem. Photobiol. B: Biol. 1993, 19, 205-215. (b) Yang, C. S.; Lee, M.-J.; Chen, L. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 83-89. (c) Nakai, S.; Inoue, Y.; Hosomi, M.; Murakami, A. Wat. Res. 2000, 34, 3026-3032.
    45. (a) Singh, R.; Barden, A.; Mori, T.; Beilin, L. Diabetologia 2001, 44, 129-146. (b) Wang, M.; Peng, X.; Ma, J.; Chao, J.; Sun, Z.; Chung Chang, R. C.; Tse, I.; Li, E. T. S. Chen, F. J. Agric. Food Chem. 2010, 58, 6692-6696.
    46. Kabalka, G. W.; Varma, R. S.; Gai, Y.-Z. Heterocycles, 1987, 24, 767.
    47. Ploypradith, P.; Batsomboon, P.; Phakhodee, W.; Ruchirawat, S. J. Org. Chem. 2009, 74, 4009-4012.
    48. Satyanarayana, G.; Suchand, B.; Krishna, J.; Ramulu, B. V.; Dibyendu, D.; Reddy, A. G. K.; Mahendar, L. Tetrahedron Lett. 2012, 53, 3861-3864.
    49. Yuan, H.; Hu, J.; Gonh, Y. Tetrahedron: Asymmetry 2013, 24, 699-705.
    50. Hellal, M.; Singh, S.; Cuny, G. D. Tetrahedron 2012, 68, 1674-1681.
    51. (a) Brossi, A.; Grethe, G.; Teitel, S.; Wildman, W. C.; Bailey, D. T. J. Org. Chem. 1970, 35, 1100-1104. (b) Schwartz, M. A.; Scott, S. W. J. Org. Chem. 1971, 36, 1827-1829. (c) Bates, H. A. J. Org. Chem. 1983, 48, 1932-1934. (d) Hoffmann-La Roche Inc. Patent: US5256783 1993. (e) Ruchirawat, S.l Chaisupakitsin, M.; Patranuwatana, N.; Cashaw, J. L.; Davis, V. E. Synth. Commun.1984, 14, 1221-1228. (f) Kumar, A. S.; Ghosh, S.; Bhima, K.; Mehta, G. N. J. Chem. Res. 2009, 482-484. (g) Li, Y.; Dong, K.; Wang, Z.; Ding, K. Angew. Chem. Int. Ed. 2013, 52, 6748-6752.
    52. (a) Locher, C.; Peerzada, N. J. Chem. Soc., Perkin Trans. 1 1999, 2, 179-184. (b) Katritzky, A. R.; He, H.-Y.; Jiang, R.; Long, Q. Tetrahedron: Asymmetry 2001, 12, 2427-2434.
    53. Kabalka, G. W.; Guindi, L. H. M. Tetrahedron Lett. 1990, 46, 7443-7457.
    54. Cheng, P.; Chen, J.-J.; Huang, N.; Wang R.-R.; Zheng, Y.-T.; Liang, Y.-Z. Molecules 2009, 14, 3176-3186.
    55. Spring, D. R.; Mestichelli, P.; Scott, M. J.; Galloway, W. R. J. D.; Selwyn, J.; Parker, J. S. Org. Lett. 2013, 15, 5448-5451.
    56. ´E. Balogh-Hergovich and G. Speier, J. Mol. Catal. 1986, 37, 309.
    57. Tokuyama, H.; Okano, K.; Fujiwara, H.; Noji, T.; Fukuyama, T. Angew. Chem. Int. Ed. 2010, 49, 5925-5929.
    58. Brown, K. L.; Chandra, T.; Zou, S. Tetrahedron Lett. 2004, 45, 7783-7786.
    59. Yao, C.-F.; Ramesh, C.; Kavala, V.; Kuo, C.-W.; Raju, B. R. Eur. J. Org. Chem. 2010, 20, 3796-3801.
    60. Borchartd, R. T.; Sinhababu, A. K. Tetrahedron Lett. 1983, 24, 227-230.
    61. Qian, S.; Wang, Z.; He, Q.; Xu, Z.; Jiang, D.; Ai, W.; Shi, R. RSC Adv. 2014, 4, 8671-8674.
    62. Kodukulla, R. P. K.; Trivedi, G. K.; Vora, J. D.; Mathur, H. H. Synth. Commun. 1994, 24, 819-832.
    63. Nycomed Gmbh Patent: WO2008071765 A1 2008.
    64. Bhatt, S.; Roy, K.; Nayak, S. K. Synth. Commun. 2010, 40, 2736-2746.
    65. Beena, N.; Sharad, F.; Abdul, R.; Pradeep, L. Chin. J. Chem. 2012, 30, 1695-1698.
    66. Fu, L.; Liu, J.; Jiang, F.; Jiang, X.; Zhang, W.; Liu, J.; Liu, W. Eur. J. Med. Chem. 2012, 54, 879-886.
    67. Zhang, B.-L.; Wang, F.-D.; Yue, J.-M. Synlett. 2006, 4, 567-570.
    68. Mesangeau, C.; Fraise, M.; Delagrange, P.; Caignard, D. H.; Boutin, J. A. ; Berthelot, P.; Yous, S. Eur. J. Med. Chem. 2011, 46, 1835-1840.

    Part 2.
    1. (a) Kohlhagen, G.; Paull, K.; Cushman, M.; Nagafuji, P.; Pommier, Y. Mol. Pharmacol.1998, 54, 50. (b) Strumberg, D.; Pommier, Y.; Paull, K.; Jayaraman, M.; Nagafuji, P.; Cushman, M. J. Med. Chem. 1999, 42, 446. (c) Cushman, M.; Jayaraman, M.; Vroman, J. A.; Fukunaga, A. K.; Fox, B. M.; Kohlhagen, G.; Strumberg, D.; Pommier, Y. J. Med. Chem. 2000, 43, 3688.
    2. (a) Wall, M. E.; Wani, M. C.; Cook, C. E.; Palmer, K. H.; McPhail, A.T.; Sim, G. A. J. Am. Chem. Soc. 1966, 88, 3888. (b) Garcia-Carbonero, R.; Supko, J. G. Clin. Cancer Res. 2002, 8, 641. (c) Thomas, C. J.; Rahier, N. J.; Hecht, S. M. Bioorg. Med. Chem. 2004, 12, 1585. (d) Morrell, A.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Bioorg. Med. Chem. Lett. 2004, 14, 3659.
    3. (a) Nagarajan, M.; Morrell, A.; Ioanoviciu, A.; Antony, S.; Kohlhagen, G.; Agama, K.; Hollingshead, M.; Pommier, Y.; Cushman, M. J. Med. Chem. 2006, 49, 6283. (b) Morrell, A.; Placzek, M.; Parmley, S.; Antony, S.; Dexheimer, T. S.; Pommier, Y.; Cushman, M. J. Med. Chem. 2007, 50, 4419. (c) Kiselev, E.; DeGuire, S.; Morrell, A.; Agama, K.; Dexheimer, T. S.; Pommier, Y.; Cushman, M. J. Med. Chem. 2011, 54, 6106. (d) Kiselev, E.; Agama, K.; Pommier, Y.; Cushman, M. J. Med. Chem. 2012, 55, 1682. (e) Nguyen, T. X.; Abdelmalak, M.; Marchand, C.; Agama, K.; Pommier, Y.; Cushman M. J. Med. Chem. 2015, 58, 31818. (f) Lv, P.-C.; Elsayed, M. S. A.; Agama, K.; Marchand, C.; Pommier, Y.; Cushman, M. J. Med. Chem. 2016, 59, 4890.
    4. Balaña-Fouce, R.; Prada, C. F.; Requena, J. M.; Cushman, M.; Pommier, Y.; Álvarez-Velilla, R.; Escudero-Martínez, J. M.; Calvo-Álvarez, E.; Pérez-Pertejo, Y.; Reguera, R. M. Antimicrob. Agents Chemother 2012, 56, 5264.
    5. Xu, Y.; Her, C. Biomolecules 2015, 5, 1652
    6. Cushman, M.; Cheng, L. J. Org. Chem. 1978, 43, 3781.
    7. (a) Nagarajan, M.; Xiao, X.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. J. Med. Chem. 2003, 46, 5712. (b) Morrell, A.; Placzek, M. S.; Steffen, J. D.; Antony, S.; Agama, K.; Pommier, Y.; Cushman, M. J. Med. Chem. 2007, 50, 2040. (c) Peterson, K. E.; Cinelli, M. A.; Morrell, A. E.; Mehta, A.; Dexheimer, T. S.; Agama, K.; Antony, S.; Pommier, Y.; Cushman, M. J. Med. Chem. 2011, 54, 4937. (d) Cinelli, M. A.; Reddy, P. V. N.; Lv, P.-C.; Liang, J.-H.; Chen, L.; Agama, K.; Pommier, Y.; van Breemen, R. B.; Cushman, M. J. Med. Chem. 2012, 55, 10844. (e) Beck, D. E.; Reddy, P. V. N.; Lv, W.; Abdelmalak, M.; Tender, G. S.; Lopez, S.; Agama, K.; Marchand, C.; Pommier, Y.; Cushman, M. J. Med. Chem. 2016, 59, 3840.
    8. (a) Bejugam, M.; Gunaratnam, M.; Muller, S.; Sanders, D.; Sewitz, S.; Fletcher, J. A.; Niedle, S.; Balasubramanian, S. ACS Med. Chem. Lett. 2010, 1, 306. (b) Ahn, G.; Lansiaux, A.; Goossens, J.-F.; Bailly, C.; Baldeyrou, B.; Schifano-Faux, N.; Grandclaudon, P.; Couture, A.; Ryckebusch A. Bioorg. Med. Chem. 2010, 18 8119. (c) Wambang, N.; Schifano-Faux, N.; Aillerie, A.; Baldeyrou, B.; Jacquet, C.; Bal-Mahieu, C.; Bousquet, T.; Pellegrini, S.; Ndifon, P. T.; Meignan, S.; Goossen, J.-F.; Lansiaux, A.; Pelinski, L. Bioorg. Med. Chem. 2016, 24, 651-660. (d) Thi, T. P.; Decuyper, L.; Quang, T. L.; The, C. P.; Thi, T. A. D.; Nguyen, H. T.; Nhat, T. G. L.; Thanh, T. N.; Thi, P. H.; D’hooghe, M. Tetrahedron Lett. 2016, 57, 466-471.
    9. (a) Ryckebusch, A.; Garcin, D.; Lansiaux, A.; Goossens, J.-F.; Baldeyrou, B.; Houssin, R.; Bailly, C.; Henichart, J.-P. J. Med. Chem. 2008, 51, 3617. (b) Zhang, X.; Wang, R.; Zhao, L.; Lu, N.; Wang, J.; You, Q.; Li, Z.; Guo, Q. Bioorg. Med. Chem. Lett. 2012, 22, 1276. (c) Ahn, G.; Schifano-Faux, N.; Goossens, J.-F.; Baldeyrou, B.; Couture, A.; Grandclaudon, P.; Lansiaux, A.; Ryckebusch, A. Bioorg. Med. Chem. Lett. 2011, 21, 2259.
    11. Liu, C.-C. Hsieh, J.-C.; Korivi, R. P.; Cheng, C.-H. Chem. Eur. J. 2015, 21, 9544.
    12. (a) Lebrin, S.; Couture, A.; Deniau, E.; Grandclaudon, P. Tetrahedron Lett. 2011, 52, 1481-1484. (b) Dubois, M.; Deniau, E.; Couture, A.; Grandclaudon, P. Synlett. 2012, 23, 1047. (c) Van, H. T. M.; Le, Q. M.; Lee, K. Y.; Lee, E.-S.; Kwon, Y.; Kim, T. S.; Le, T. N.; Lee, S.-H.; Cho, W.-J. Bioorg. Med. Chem. Lett. 2007, 17, 5763. (d) Cho, W.-J.; Le, Q. M.; Van, H. T. M.; Lee, K. Y.; Kang, B. Y.; Lee, E.-S.; Lee, S. K.; Kwon, Y. Bioorg. Med. Chem. Lett. 2007, 17, 3531. (e) Cho, W.-J.; Park, M.-J.; Imanishi, T.; Chung, B.-H. Chem. Pharm. Bull. 1999, 47, 900.
    13. Kavala, V.; Wang, C.-C.; Barange, D. K.; Kuo, C.-W.; Lei, P.-M.; Yao, C.-F. J. Org. Chem. 2012, 77, 5022.
    14. Liu, L.; Hu, J.; Wang, X.-C.; Zhong, M.-J.; Liu, X.-Y.; Yang, S.-D.; Liang Y.-M. Tetrahedron 2012, 68, 5391.
    15. (a) Okuro, K.; Furuune, M.; Miura, M.; Nomura, M. J. Org. Chem. 1993, 58, 7606. (b) Hennessy, E. J.; Buchwald, S. L. Org. Lett. 2002, 4, 269.
    16. (a) Gawande, S. D.; Zanwar, M. R.; Kavala,V.; Kuo, C.‐W.; Rajawinslin, R. R.; Yao, C.‐F. Adv. Synth. Catal. 2015, 357, 168.(b) Gawande, S. D.; Kavala, V.; Zanwar, M. R.; Kuo, C.‐W.; Huang,W.‐C.; Kuo,T.‐S.; Huang, H.‐N.; He, C.‐H.; Yao, C.‐F. Adv. Synth. Catal. 2014, 356, 2599. (c) Kavala, V.; Wang, C.‐C.; Wang, Y.‐H.; Kuo, C.‐W.; Janreddy, D.; Huang, W.‐C.; Kuo,T.‐S.; He, C.-H.; Chen, M.‐L.; Yao, C.‐F. Adv. Synth. Catal. 2014, 356, 2609. (d) Kotipalli, T.; Kavala, V.; Donala J.; Kuo, C.-W.; Kuo,T.-S.; Huang, H.-N.; He, C.-H.; Yao, C.-F. RSC Adv. 2014, 2274. (e) Kavala, V.; Janreddy, D.; Raihan, M. J.; Kuo, C.‐W.; Ramesh, C.; Yao, C.‐F. Adv. Synth. Catal. 2012, 354, 2609.
    17. 2-Iodobenzamide derivatives 1 was prepared from the corresponding 2-iodobenzoic acid according to the following papers: (a) A. M. Suess, M. Z. Ertem, C. J. Cramer, S. S. Stahl, JACS 2013, 135, 9797-9804. (b) N. Zhang, B. Li, H. Zhong, J. Huang, Org. Biomol. Chem. 2012, 10, 9429-9439.
    18. Indandione 2a was commercially available. 5,6-dimethoxyindandione 2b was prepared according to the following papers: (a) Sterling Winthrop Inc., Patent: US5554620, A1, 1996. (b) G. Tóth, K. E. Kövér, Synth. Commun. 1995, 25, 3067-3074. (c) J. D. Enas, J. G. Garcia, C. A. Mathis, J. M. Gerdes, J. Fluorine Chem. 1993, 63, 233-241. 5,6-Methylenedioxyindandione 2c was prepared according to the following papers: (d) P. V. R. Acharyulu, P. K. Dubey, P. V. V. P. Reddy, T. Suresh, Synth. Commun. 2009, 39, 3217-3231. (e) Ube Industries, Ltd., Patent: EP1621529 A1, 2006. (f) Schering Corporation, Patent: WO200448322 A1, 2004. (g) P. Dallemagne, S. Rault, J. C. Pilo, M. P. Foloppe, M. Robba, Tetrahedron Lett. 1991, 32, 6327-6328. (h) H. E. Zimmerman, M.-L. Viriot-Villaume, J. Am. Chem. Soc. 1973, 95, 1274-1280. 5-bromoindandione 2d was prepared according to the following papers: (i) Tso, S.-C.; Lou, M.; Wu, C.-Y.; Gui, W.-J.; Cuang, J. L.; Morlock, L. K.; Williams, N. S.; Wynn, R. M.; Qi, X.; Chuang, D. T. J. Med. Chem. 2017, 60, 1142-1150. (j) Peloton Therapeutics Inc., Patent: 201535223 A1, 2015. 2-Nitroindandione 2e was prepared according to ref. 18j.

    無法下載圖示 本全文未授權公開
    QR CODE